A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.

At every level of leadership, Premier’s experts are driving healthcare forward.

Leadership
Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.  

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.  

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Data, inquiry and intervention services.

Our most recent insights, articles and more, all in one place.  

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

Hospitals Stockpile Drug Trump Says Could Treat Covid-19

Published in: Bloomberg

From March 1 through March 17, U.S. hospitals bought an average of 16,110 units of hydroxychloroquine, compared with an average 8,800 units a month from January 2019 through February 2020, according to Premier Inc., which helps 4,000 member hospitals buy and manage their supplies.

Hydroxychloroquine and its more-toxic cousin chloroquine, which are also commonly used to treat rheumatoid arthritis and lupus, haven’t been approved by the U.S. Food and Drug Administration for Covid-19. While Trump has touted some reports from doctors outside the U.S. suggesting hydroxychloroquine could be a promising treatment, there have been no large-scale clinical trials to support those claims.

Even so, the expected surge in the number of Covid-19 patients has led health-care systems to try to stock up on potential treatments. With hospitals in regions with high infection rates already stretched, many are trying to assure access to medications as more patients are diagnosed.

Soumi Saha, senior director of advocacy at Premier, said she’s found wholesale distribution channels have been entirely depleted of their hydroxychloroquine supply.

Full Story

Login Register Change Registration